Trial
NCT03132571
Naltrexone-Bupropion Versus Placebo-Bupropion for Weight Loss in Schizophrenia
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Yale University
Collaborators
—
Condition
Schizophrenia
Intervention
Naltrexone
Why stopped
Study discontinued due to funding.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-08-07